Agricultural exposure and risk of ovarian cancer in the AGRIculture and CANcer (AGRICAN) cohort.

Agriculture Farmers Pesticides

Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 05 07 2023
accepted: 17 12 2023
medline: 11 1 2024
pubmed: 11 1 2024
entrez: 10 1 2024
Statut: aheadofprint

Résumé

Ovarian cancer is rare with a poor prognosis and few established risk factors. Hormones and reproductive factors significantly impact its development, suggesting a potential link with endocrine disrupters. In the AGRICAN cohort, 59 391 female farmers completed data on lifelong agricultural exposures and reproductive life. Cox models with attained age as timescale (HR and 95% CI) were used. The role of hormonal factors as potential confounders was considered along with specific time windows for exposure (childhood, puberty and menopause). Female farmers were the reference group (for the principal analyses). Between enrolment (2005-2007) and the end of follow-up (31 December 2017), 262 incident ovarian cancers were identified. An increased risk was observed for females involved in pigs (HR=2.12 (95% CI 1.27 to 3.52)) including during puberty (HR=1.83 (95% CI 1.13 to 2.94)), fruit-growing (HR=2.17 (95% CI 1.09 to 4.30)) and potato seed treatment (HR=2.81 (95% CI 1.29 to 6.09)). Conversely, females born on farms growing grain cereals (HR=0.64 (95% CI 0.46 to 0.90)) or pig-breeding (HR=0.78 (95% CI 0.55 to 1.12)) presented a reduced risk of ovarian cancer. Triazine herbicide exposure was not associated with ovarian cancer. The effect of agricultural exposures remained unchanged in multivariate models considering contraception, parity, puberty age, menopause age and body mass index. This study is the first to assess the association between specific agricultural exposures and ovarian cancer comprehensively. Some of the positive associations observed suggest that some pesticide exposure (especially during puberty) could play a role in the development of ovarian cancer. On the other hand, agricultural exposure during early life could have a protective effect, as observed for lung cancer among farmers. Finally, we did not confirm the previous putative effect of exposure to triazine herbicides.

Sections du résumé

BACKGROUND BACKGROUND
Ovarian cancer is rare with a poor prognosis and few established risk factors. Hormones and reproductive factors significantly impact its development, suggesting a potential link with endocrine disrupters.
METHODS METHODS
In the AGRICAN cohort, 59 391 female farmers completed data on lifelong agricultural exposures and reproductive life. Cox models with attained age as timescale (HR and 95% CI) were used. The role of hormonal factors as potential confounders was considered along with specific time windows for exposure (childhood, puberty and menopause). Female farmers were the reference group (for the principal analyses).
RESULTS RESULTS
Between enrolment (2005-2007) and the end of follow-up (31 December 2017), 262 incident ovarian cancers were identified. An increased risk was observed for females involved in pigs (HR=2.12 (95% CI 1.27 to 3.52)) including during puberty (HR=1.83 (95% CI 1.13 to 2.94)), fruit-growing (HR=2.17 (95% CI 1.09 to 4.30)) and potato seed treatment (HR=2.81 (95% CI 1.29 to 6.09)). Conversely, females born on farms growing grain cereals (HR=0.64 (95% CI 0.46 to 0.90)) or pig-breeding (HR=0.78 (95% CI 0.55 to 1.12)) presented a reduced risk of ovarian cancer. Triazine herbicide exposure was not associated with ovarian cancer. The effect of agricultural exposures remained unchanged in multivariate models considering contraception, parity, puberty age, menopause age and body mass index.
CONCLUSION CONCLUSIONS
This study is the first to assess the association between specific agricultural exposures and ovarian cancer comprehensively. Some of the positive associations observed suggest that some pesticide exposure (especially during puberty) could play a role in the development of ovarian cancer. On the other hand, agricultural exposure during early life could have a protective effect, as observed for lung cancer among farmers. Finally, we did not confirm the previous putative effect of exposure to triazine herbicides.

Identifiants

pubmed: 38199811
pii: oemed-2023-109089
doi: 10.1136/oemed-2023-109089
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

S Dabakuyo-Yonli (S)
S Bara (S)
A M Bouvier (AM)
T Busquet (T)
G Coureau (G)
M Delanoé (M)
P Grosclaude (P)
N Vigneron (N)
P Herbrecht (P)
J P Valera (JP)
B Lapotre-Ledoux (B)
A Alves (A)
P Bouyssou (P)
K E Hammas (KE)
E Rigaud (E)
M Maynadié (M)
F Molinié (F)
A Monnereau (A)
A Paumier (A)
J Jarriges (J)
S Laude (S)
X Troussard (X)
M Velten (M)
F Baussin Rabouin (F)
A S Woronoff (AS)

Informations de copyright

© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Marine Renier (M)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France marine.renier@unicaen.fr.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Juliette Hippert (J)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Weiswald Louis-Bastien (W)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Séverine Tual (S)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Matthieu Meryet-Figuiere (M)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Nicolas Vigneron (N)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Registre général des tumeurs du Calvados, Caen, France.

Elisabeth Marcotullio (E)

Caisse Centrale de la Mutualite Sociale Agricole, Paris, France.

Isabelle Baldi (I)

INSERM, Bordeaux Population Health Research Center, Team EPICENE, UMR 1219, Université de Bordeaux, Bordeaux, France.
CHU de Bordeaux, Pôle de Santé Publique, Service de Médecine du Travail et Pathologies Professionnelles, Bordeaux, France.

Pierre Lebailly (P)

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de Recherche (UMR) 1086 ANTICIPE, Caen, France.
Centre François Baclesse Centre de Lutte Contre le Cancer, Caen, France.
Université de Caen Normandie, Caen, France.

Classifications MeSH